Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: A multi-regional health economic analysis

This publication has 83 references indexed in Scilit:

• Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
  The Lancet, 2007
• Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted
  BMJ, 2007
• Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
  International Journal of Cancer, 2007
• Model for Assessing Human Papillomavirus Vaccination Strategies
  Emerging Infectious Diseases, 2007
• Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
  British Journal of Cancer, 2006
• High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
  British Journal of Cancer, 2006
• Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
  British Journal of Cancer, 2003
• Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
  British Journal of Cancer, 2003
• Willingness to Pay for a Quality-adjusted Life Year
  Medical Decision Making, 2000
• The management of cervical intra-epithelial neoplasia (CIN): Extensiveness and costs in The Netherlands
  European Journal Of Cancer, 1995